Core Insights - Earth Science Tech, Inc. (ETST) has received clearance from the Financial Industry Regulatory Authority (FINRA) for its Form 211 application, allowing for the initiation of priced quotations for its securities [1][2][3] Company Overview - ETST operates as a strategic holding company focused on acquiring and scaling high-potential operating businesses, with current operations in compounding pharmaceuticals, telemedicine, and real estate development through various subsidiaries [3] - The company's subsidiaries include RxCompoundStore.com, Peaks Curative, Avenvi, Mister Meds, Earth Science Foundation, Las Villas Health Care, and an 80% interest in MagneChef [3] Subsidiary Highlights - **RxCompoundStore.com, LLC**: A fully licensed compounding pharmacy operating in multiple states, actively pursuing licensure in remaining U.S. states [4] - **Mister Meds, LLC**: A compounding pharmacy in Texas with advanced sterile compounding capabilities, applying for licensure in additional states [5] - **Peaks Curative, LLC**: A telemedicine platform offering consultations for compounded medications, expanding into the veterinary market through the acquisition of Zoolzy.com [6] - **Las Villas Health Care, Inc.**: A healthcare facility focused on the Spanish-speaking community, providing advanced health treatments [8] - **Avenvi, LLC**: A diversified real estate company managing a $10 million share repurchase program and overseeing investment activities for ETST [9] - **MagneChef**: A direct-to-consumer retail brand developing new cooking products and expanding into the BBQ tool market through the acquisition of BBQraft [9] - **Earth Science Foundation, Inc.**: A nonprofit organization providing financial support for prescription costs at ETST's pharmacies [10] Strategic Importance - The clearance of Form 211 is viewed as a critical milestone for ETST, expected to enhance shareholder value, improve liquidity, and provide greater visibility for executing its business plan [3]

Financial Data and Key Metrics Changes - Revenue for Q1 2025 was $500.8 million, a 7.1% increase from $467.6 million in Q1 2024, representing an 8.9% growth on a revenue per day basis [8][11] - Adjusted EBITDA increased to $102.7 million in Q1 2025 from $96.1 million in Q1 2024, a 6.8% increase, with adjusted EBITDA margin slightly decreasing from 20.6% to 20.5% [8][18] - Net income was $40.6 million, lower than the same quarter last year, primarily due to increased interest expenses and transaction costs related to acquisitions [9][10] Business Line Data and Key Metrics Changes - Total patient visits per day increased by 3.2% year over year to 50,900, with a 0.6% increase to 49,600 when excluding the Nova acquisition [5][11] - Workers' compensation revenue was $302.1 million, an 8% increase year over year, with visits per day up 2.4% [12] - Employer services revenue increased by 6.2% to $160.1 million, with visits per day up 3.9% [13] Market Data and Key Metrics Changes - The company reported strong growth in both workers' compensation and employer services, indicating a positive trend in the occupational health market [6][9] - The acquisition of Nova Medical Centers and other strategic acquisitions are expected to enhance market presence and service offerings [7][22] Company Strategy and Development Direction - The company is focused on expanding its footprint through acquisitions, with the recent Nova acquisition and plans for the Pivot On-site acquisition, which will significantly increase its operational scale [7][24] - The strategy includes enhancing employer relationships and scaling the on-site health segment, which is projected to double in revenue due to the Pivot acquisition [24][25] - The company aims to maintain a leverage ratio of approximately 3.5 times by the end of 2025 and 3.0 times within the next 18 to 24 months, focusing on debt repayment and organic growth initiatives [26] Management's Comments on Operating Environment and Future Outlook - Management noted that despite macroeconomic uncertainties, there has been no observed impact on visit volumes, which is seen as a positive indicator [27][28] - The company is well-positioned to handle potential economic slowdowns, leveraging its history of managing costs effectively during downturns [31][32] - Future growth is anticipated from potential increases in manufacturing jobs due to reshoring efforts, which could drive visit growth at the company's centers [28][29] Other Important Information - The company declared a cash dividend of $0.0625 per share, payable on May 29, 2025 [21] - The company ended Q1 2025 with a total debt balance of $1.6 billion and a cash balance of $52 million, with a net leverage ratio of 3.9 times [20] Q&A Session Summary Question: Discussion on Employer Services volumes and turnaround - Management indicated that the positive performance in Employer Services volumes is attributed to improved sales and marketing efforts, with cautious optimism for continued growth [39][41] Question: Future growth with recent acquisitions - Management emphasized the importance of scaling operations and enhancing partnerships within the managed care ecosystem to drive future growth [43][44] Question: Workers' compensation visit growth and long-term outlook - Management acknowledged that while organic growth was slightly slower than expected, they anticipate positive growth moving forward [53][54] Question: Impact of inflation on rates - Management explained that rates typically adjust in line with inflation, with historical patterns showing timely adjustments to fee schedules [61][64] Question: Cost structure and labor efficiency - Management highlighted that labor constitutes a significant portion of costs, with teams effectively managing staffing levels in response to visit volumes [102][103]

As filed with the Securities and Exchange Commission on November 1, 2023 Registration No. 333-268711 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 6 TO FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 _______________________ LYTUS TECHNOLOGIES HOLDINGS PTV. LTD. (Exact Name of Registrant as Specified in its Charter) _______________________ British Virgin Islands 7841 Not applicable (State or Other Jurisdiction of Incorporation or Organization) (Primary ...